skip to main content

H.R. 5605: Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act

About the bill

Source: Republican Policy Committee

H.R. 5605 establishes a four-year demonstration program to increase access to treatment for opioid use disorder. The demonstration would provide incentive payments and funding for care management services based on criteria such as patient engagement, use of evidence-based treatments, and treatment length and intensity. Under the bill, the Secretary of Health and Human Services would be directed to encourage other payers to coordinate payments for opioid use disorder treatments and to evaluate the extent to which the demonstration reduces hospitalizations, increases the use of medication-assisted treatments, and improves the ...

Sponsor and status

Raul Ruiz

Sponsor. Representative for California's 36th congressional district. Democrat.

Read Text »
Last Updated: Jun 20, 2018
Length: 22 pages
Introduced:

Apr 24, 2018

Status:

Passed House (Senate next) on Jun 19, 2018

This bill passed in the House on June 19, 2018 and goes to the Senate next for consideration.

Prognosis:

49% chance of being enacted according to Skopos Labs (details)

History

Apr 24, 2018
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

May 17, 2018
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Jun 12, 2018
 
Reported by House Committee on Energy and Commerce

A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.

Jun 19, 2018
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.

Pending
 
Passed Senate

Pending
 
Signed by the President

H.R. 5605 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 5605 — 115th Congress: Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act.” www.GovTrack.us. 2018. August 20, 2018 <https://www.govtrack.us/congress/bills/115/hr5605>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.